VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European CE Mark approval of SeeLyra, the company’s next generatio…
Author: Business Wire
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
NEW HAVEN, Conn.–(BUSINESS WIRE)–Yarrow Bioscience, Inc. (“Yarrow” or the “Company”) (Nasdaq: YARW), a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, today announced the pricing of…
حصول Johnson & Johnson على علامة CE للعدسات اللاصقة القابلة لإعادة الاستخدام ACUVUE OASYS MAX
ليمريك، أيرلندا–(BUSINESS WIRE)–أعلنت اليوم شركة Johnson & Johnson (بورصة نيويورك: JNJ) عن حصولها على علامة CE للعدسات اللاصقة ACUVUE OASYS MAX 2-Week،*** وهي عدسات لاصقة جديدة قابلة لإعادة الاستخدام، تتميز بتقنيات MAX المملوكة للشركة والمصممة لت…
Resumen: Johnson & Johnson obtiene el marcado CE para las lentillas reutilizables ACUVUE OASYS MAX
LIMERICK, Irlanda–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) anunció hoy la obtención del marcado CE para ACUVUE OASYS MAX 2-Week,*** unas nuevas lentillas reutilizables que incluyen las tecnologías patentadas MAX, diseñadas para ofrecer una c…
Johnson & Johnson erhält CE-Kennzeichnung für wiederverwendbare Kontaktlinsen der Marke ACUVUE OASYS MAX
LIMERICK, Irland–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) gab heute bekannt, dass das Unternehmen die CE-Kennzeichnung für ACUVUE OASYS MAX 2-Week*** erhalten hat, eine neue wiederverwendbare Kontaktlinse mit proprietären MAX-Technologien, d…
Johnson & Johnson reçoit le marquage CE pour les lentilles de contact réutilisables ACUVUE OASYS MAX
LIMERICK, Irlande–(BUSINESS WIRE)–Johnson & Johnson (NYSE : JNJ) annonce aujourd’hui avoir reçu le marquage CE pour ACUVUE OASYS MAX 2-Week,*** une nouvelle lentille de contact réutilisable dotée de technologies MAX exclusives conçues pour offrir…
Riassunto: Johnson & Johnson riceve il marchio CE per le lenti a contatto riutilizzabili ACUVUE OASYS MAX
LIMERICK, Irlanda–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) oggi ha annunciato di aver ricevuto il marchio CE per ACUVUE OASYS MAX 2-Week,*** una nuova lente a contatto riutilizzabile basata su tecnologie proprietarie MAX progettate per garan…
Samenvatting: Johnson & Johnson ontvangt CE-markering voor herbruikbare ACUVUE OASYS MAX-contactlenzen
LIMERICK, Ierland–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) heeft vandaag aangekondigd dat het de CE-markering heeft ontvangen voor ACUVUE OASYS MAX 2-Week,*** een nieuwe herbruikbare contactlens met eigen MAX-technologieën, ontworpen voor su…
Yarrow Bioscience Announces Proposed Underwritten Public Offering
NEW HAVEN, Conn.–(BUSINESS WIRE)–Yarrow Bioscience, Inc. (“Yarrow” or the “Company”) (Nasdaq: YARW), a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, today announced that it has co…
Eyexora to Participate in the Citizens Virtual Private Ophthalmology Summit
NEW YORK & SINGAPORE–(BUSINESS WIRE)–Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, today announced that Theresa Heah, MD, MBA, Chief Executive Officer and Vice Chair, will participat…
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
LIMERICK, Ireland–(BUSINESS WIRE)–Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX 2-Week, a new reusable contact lens featuring proprietary MAX technologies.
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today released a new report entitled The Future of Refr…
Ashvattha Therapeutics Announces Investor and Conference Presentations
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company developing an at-home subcutaneous (subQ) monthly treatment, announced presentations at HC Wainwright Conference, Ophthalmology Futures Retina Forum, …
Tenpoint Therapeutics to Participate in Upcoming Investor Conferences and Medical Meetings
LONDON & WARREN, N.J.–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced participation in upcoming inv…
Warby Parker Announces Participation in the Goldman Sachs 33rd Annual Global Retailing Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Goldman Sachs 33rd Annual Global Retailing Conference …
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointme…
Heru Announces the Launch of PretestPro™ for the Heru Prime VR-Powered Diagnostic Headset
MIAMI–(BUSINESS WIRE)– #Glaucoma–Heru announced the U.S. launch of the new PretestPro on its Heru Prime wearable platform. PretestPro runs four pretest exams in just 90 seconds.
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
GENEVA–(BUSINESS WIRE)–Alcon Launches UNITY® M, a Premium Ophthalmic Microscope Delivering Precise Control
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointme…
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the publication of new research on real world experience with enVi…